Sarepta’s Elevidys: Boxed Warning On Cardiotoxicity Events Not Needed, US FDA Says

 
• By Sue Sutter
  
Myocarditis notebook
Cardiotoxicities such as myocarditis did not rise to the level of a boxed warning on Elevidys labeling, the FDA said. (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Cell & Gene Therapies

More from United States